HRTX - Heron Therapeutics Inc. (HRTX) Q1 2024 Earnings Call Transcript
2024-05-07 14:38:07 ET
Heron Therapeutics, Inc. (HRTX)
Q1 2024 Earnings Conference Call
May 07, 2024 08:30 AM ET
Company Participants
Craig Collard - Chief Executive Officer
Ira Duarte - Executive Vice President and Chief Financial Officer
William Forbes - Executive Vice President, Chief Development Officer
Kevin Warner - SVP of Medical Affairs strategy engagements
David Barozzino - Vice President of Sales, Acute Care
Conference Call Participants
Serge Berlanger - Needham
Carl Byrnes - Northland Capital Markets
Tim Chiang - Capital One
Presentation
Operator
Thank you for standing by. My name is Alex and I will be your conference operator today. At this time, I would like to welcome everyone to the Heron Therapeutics Q1 2024 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].
I would now like to turn the call over to Melissa Dorel [ph], Executive Director, Legal. Please go ahead.
Unidentified Company Representative
Thank you, operator, and good morning everyone. Thank you for joining us on the Heron Therapeutics conference call this afternoon to discuss the company's financial results for the quarter ended March 31, 2024. With me today from Heron are Craig Collard, Chief Executive Officer; Ira Duarte, Executive Vice President, Chief Financial Officer; Bill Forbes, Executive Vice President, Chief Development Officer. For those of you participating via conference call, slides are made available via webcast and can also be accessed via the Investor Relations page of our website following the conclusion of today's call....
Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript